TGFB1 and breast cancer: Direct contact between platelets and MCF-7 through integrin α2β1 has also been observed in breast cancer, which not only activates the Wnt-β-catenin pathway and promotes the expression of EMT-related proteins, but also synergistically facilitates EMT by inducing the TGFβ1 autocrine from tumor cells [44].